Christopher Prentice, who joined Mazor Robotics Ltd in 2010, has been promoted to Senior Vice President, America and Global Marketing. He will oversee Mazor’s commercial and sales operations in the Americas while also continuing to oversee the company’s global marketing strategy. He will report directly to CEO Ori Hadomi and will be a member of the corporate senior executive team.
Prentice New VP at Mazor Robotics
1 min read Premium comments
Prior to joining Mazor, Prentice held leadership positions in marketing & sales at Ethicon Endo-Surgery, a Johnson & Johnson company, Intuitive Surgical, Inc., and served on the leadership team of Tampa General Hospital. Chris graduated from the United States Military Academy at West Point, has an MBA from Western New England University, and an MHA from the University of South Florida.
“Chris has made a significant contribution to the success of Mazor and I believe that his new responsibilities will contribute to the growth and success of the company, ” commented Ori Hadomi.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.